Literature DB >> 30508430

Effect of Liraglutide on Cardiovascular Outcomes in Elderly Patients: A Post Hoc Analysis of a Randomized Controlled Trial.

Matthew P Gilbert1, Stephen C Bain2, Edward Franek3, Esteban Jodar-Gimeno4, Michael A Nauck5, Richard Pratley6, Rosângela Roginski Réa7, José Francisco Kerr Saraiva8, Søren Rasmussen9, Karen Tornøe9, Bernt Johan von Scholten9, John B Buse10.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30508430     DOI: 10.7326/M18-1569

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  10 in total

1.  Cardiovascular prevention in elderly patients.

Authors:  Clara Bonanad; Rosa Fernández-Olmo; Sergio García-Blas; Jose Antonio Alarcon; Pablo Díez-Villanueva; Carmen Rus Mansilla; Héctor García-Pardo; Pablo Toledo; Ana Ayesta; Eva Pereira; Antoni Carol; Almudena Castro-Conde; Carmen de Pablo-Zarzoso; Manuel Martínez-Sellés; Vicente Arrarte; Raquel Campuzano; Albert Ariza-Solé
Journal:  J Geriatr Cardiol       Date:  2022-05-28       Impact factor: 3.189

Review 2.  Type 2 diabetes mellitus in older adults: clinical considerations and management.

Authors:  Srikanth Bellary; Ioannis Kyrou; James E Brown; Clifford J Bailey
Journal:  Nat Rev Endocrinol       Date:  2021-06-25       Impact factor: 43.330

Review 3.  Diabetes in ageing: pathways for developing the evidence base for clinical guidance.

Authors:  Medha N Munshi; Graydon S Meneilly; Leocadio Rodríguez-Mañas; Kelly L Close; Paul R Conlin; Tali Cukierman-Yaffe; Angus Forbes; Om P Ganda; C Ronald Kahn; Elbert Huang; Lori M Laffel; Christine G Lee; Sei Lee; David M Nathan; Naushira Pandya; Richard Pratley; Robert Gabbay; Alan J Sinclair
Journal:  Lancet Diabetes Endocrinol       Date:  2020-10       Impact factor: 32.069

4.  Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis.

Authors:  Takayoshi Kanie; Atsushi Mizuno; Yoshimitsu Takaoka; Takahiro Suzuki; Daisuke Yoneoka; Yuri Nishikawa; Wilson Wai San Tam; Jakub Morze; Andrzej Rynkiewicz; Yiqiao Xin; Olivia Wu; Rui Providencia; Joey Sw Kwong
Journal:  Cochrane Database Syst Rev       Date:  2021-10-25

Review 5.  Evaluating glucose-lowering treatment in older people with diabetes: Lessons from the IMPERIUM trial.

Authors:  Alan J Sinclair; Simon R Heller; Richard E Pratley; Ran Duan; Robert J Heine; Andreas Festa; Jacek Kiljański
Journal:  Diabetes Obes Metab       Date:  2020-03-11       Impact factor: 6.577

6.  Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial.

Authors:  Lawrence A Leiter; Stephen C Bain; Irene Hramiak; Esteban Jódar; Sten Madsbad; Theis Gondolf; Thomas Hansen; Ingrid Holst; Ildiko Lingvay
Journal:  Cardiovasc Diabetol       Date:  2019-06-06       Impact factor: 9.951

7.  Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).

Authors:  Grazia Daniela Femminella; Eleni Frangou; Sharon B Love; Gail Busza; Clive Holmes; Craig Ritchie; Robert Lawrence; Brady McFarlane; George Tadros; Basil H Ridha; Carol Bannister; Zuzana Walker; Hilary Archer; Elizabeth Coulthard; Ben R Underwood; Aparna Prasanna; Paul Koranteng; Salman Karim; Kehinde Junaid; Bernadette McGuinness; Ramin Nilforooshan; Ajay Macharouthu; Andrew Donaldson; Simon Thacker; Gregor Russell; Naghma Malik; Vandana Mate; Lucy Knight; Sajeev Kshemendran; John Harrison; Christian Hölscher; David J Brooks; Anthony Peter Passmore; Clive Ballard; Paul Edison
Journal:  Trials       Date:  2019-04-03       Impact factor: 2.279

8.  Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: A subgroup analysis of the randomized CAROLINA trial.

Authors:  Mark A Espeland; Richard E Pratley; Julio Rosenstock; Takashi Kadowaki; Yutaka Seino; Bernard Zinman; Nikolaus Marx; Darren K McGuire; Knut Robert Andersen; Michaela Mattheus; Annett Keller; Maria Weber; Odd Erik Johansen
Journal:  Diabetes Obes Metab       Date:  2020-12-06       Impact factor: 6.577

9.  Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial.

Authors:  Matthew C Riddle; Hertzel C Gerstein; Denis Xavier; William C Cushman; Lawrence A Leiter; Peter J Raubenheimer; Charles M Atisso; Sohini Raha; Oralee J Varnado; Manige Konig; Mark Lakshmanan; Edward Franek
Journal:  J Clin Endocrinol Metab       Date:  2021-04-23       Impact factor: 5.958

Review 10.  Hypoglycaemic therapy in frail older people with type 2 diabetes mellitus-a choice determined by metabolic phenotype.

Authors:  Alan J Sinclair; Daniel Pennells; Ahmed H Abdelhafiz
Journal:  Aging Clin Exp Res       Date:  2022-06-20       Impact factor: 4.481

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.